Chronic Lymphocytic Leukemia Research

Chronic Lymphocytic Leukemia Research is a research topic within Genetics. Science Explorer counts 54k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL). It covers topics such as the use of BTK inhibitors (e.g., Ibrutinib), the role of rituximab, TP53 mutations, and the impact of immunoglobulin mutations. Additionally, it explores therapeutic targets and outcomes in patients with Waldenström macroglobulinemia.

• Chronic Lymphocytic Leukemia
• Genomic Aberrations
• BTK Inhibitors
• Rituximab
• Ibrutinib
• Prognostic Factors
• TP53 Mutation
• Waldenström Macroglobulinemia
• Immunoglobulin Mutation
• Therapeutic Targets